Replies to post #87 on Eli Lilly and Company (LLY)

[MIKEY501]

NSAV news out on contract with LLY
$$$$$$$$$$$$$$

NSAV 8-K officially Eli LillY contract VSRI 12/21/2017

Shanghai based Vital Strategic Research Institute (VSRI), has signed an agreement with Eli Lilly and Company. Under the terms of the agreement, VSRI will provide Eli Lilly with an assessment of Cardio Vascular Disease (CVD) among newly diagnosed diabetes patients at increased risk of CVD in China

*******Copie of Contract*************
http://nsavholdinginc.com/files/VSRI-Eli-Lilly.pdf

Ceo James Tilton wants to be clear with everything

Officieel op Sec EDGAR Search Results
https://www.sec.gov/cgi-bin/browse-edgar?company=Net+Savings+Link%2C+Inc.&owner=exclude&action=getcompany

OTC Reporting
https://www.otcmarkets.com/stock/NSAV/news

ELI LILLY AND COMPANY AND SUBSIDIARIES 2016
Financial Highlights>>>> Revenu 2016 $ 21Billion !!! Netto income 2.7Billion
https://en.wikipedia.org/wiki/Eli_Lilly_and_Company

Eli Lilly builds $23B-plus Sales Forecast for 2017 on diabetes, cancer launches
https://www.fiercepharma.com/pharma/facing-cialis-patent-expiration-and-pricing-strife-diabetes-eli-lilly-eyes-new-launches-for

**China spends $50 billion treating diabetes and related diseases every year,
https://blogs.wsj.com/chinarealtime/2016/11/14/chinas-diabetes-problem-from-1-to-10-in-36-years/

**China, about 230 million people have cardiovascular disease.1
http://www.wpro.who.int/china/mediacentre/factsheets/cvd/en/

ELI LILLY AND CO Share price $ 87.00 Not a bad company to work with!!!
https://www.marketwatch.com/investing/stock/lly